CESCA THERAPEUTICS INC has a total of 14 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and chemical engineering are OTITOPIC INC, PASCU CONSTANTIN and PALMAYA PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | China | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | United States | 3 | |
#5 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Chemical engineering | |
#4 | Biotechnology | |
#5 | Basic materials chemistry | |
#6 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Diagnosis and surgery | |
#5 | Separation | |
#6 | Preservation of human bodies | |
#7 | Microbiology | |
#8 | Chemical or physical laboratory devices | |
#9 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Sethi Dalip | 12 |
#2 | Ponemone Venkatesh | 8 |
#3 | Cohan Gary R | 4 |
#4 | Bruque Nicolas A | 4 |
#5 | Heiserman James | 4 |
#6 | Baker Bruce | 4 |
#7 | Harris Kenneth | 4 |
#8 | Lacher Markud D | 4 |
#9 | Harris Kenneth Lee | 4 |
#10 | Xu Xiaochun | 3 |
Publication | Filing date | Title |
---|---|---|
WO2018129467A1 | Devices and methods for bio-processing cellular samples | |
WO2017214196A1 | Adjustable control of cell compositions during centrifugation | |
CN107949390A | Intramuscular administration for the autologous bone marrow for the treatment of | |
WO2014110180A1 | Rapid infusion of autologous bone marrow derived stem cells |